1
Human Protein Network
Identified 2 high-affinity protein targets: PIM1 and RSK2
94%
2
Molecular Docking
Strong binding affinity to PIM1 (4XH6) and RSK2 (4GUE) active sites
91%
3
Docking Reasoning Agent
Analyzed functional groups for binding contribution and modifiability
94%
4
Molecular Dynamics
Stable complex formation over 100ns simulation trajectory
88%
5
Toxicity Prediction
Low toxicity profile with favorable safety margins
96%
6
Dissolving Agent
Optimal solubility in ethanol and DMSO systems
93%
7
Shelf Life
Eudragit polymer provides optimal 24+ month stability
91%
8
Nanoparticle Size
Optimal particle size of 95nm achieved with Acetone-TPGS
88%
9
Lipid Bioavailability
Phospholipid complex increases bioavailability 3-5x
94%
10
Excipients Risk Quality Control
Minor stability concerns under UV exposure identified
85%
11
Cancer Reasoning Agent
Significant activity against colorectal and pancreatic cancer lines
92%
12
Chemical Patent Reasoning Agent
Generated 8 patent claims covering pharmacophore model and therapeutic applications
96%
13
IND Application Agent
Botanical IND application draft prepared per FDA guidance (89% complete)
89%